QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

BXPTICKER

Bxp, Inc.

NEUTRAL stock

Congress has disclosed 6 buys and 8 sells of BXP (Bxp, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

6
Buy
8
Sell
-2
Net
9
Active politicians

Round-trip watch Still on the books

Members who disclosed buying BXP and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Rohit Khanna 2026-09-11 $63.97 $62.80 -1.8% ↩ near entry
Alan Armstrong 2026-03-27 $49.64 $62.80 +26.5% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Finance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
33.79
▲ pricier than Finance (median 17.2)
how it's calculated
P/E = price ÷ earnings per share
$62.80 ÷ $1.86 = 33.79
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
1.94
≈ in line with Finance (median 1.8)
how it's calculated
P/B = price ÷ book value per share
$62.80 ÷ $32.29 = 1.94
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Finance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 10820 Epstein Wall Street Records Act of 2026 Finance and Financial Sector 2026-10-15
HR 10821 To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. Finance and Financial Sector 2026-10-15
S 4395 Terrorism Risk Insurance Program Reauthorization Act of 2026 Finance and Financial Sector 2026-10-05
S 1564 Floodplain Enhancement and Recovery Act Finance and Financial Sector 2026-10-05
S 5644 A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. Finance and Financial Sector 2026-09-30

14 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Rohit Khanna House BUY OCR Child 2026-09-11 20 days -5.8% $1K–$15K 97.9 ↗ filing
Alan Armstrong Senate BUY ◆ insider divergence · moderate Self 2026-03-27 116 days +36.1% $1K–$15K 82.9 ↗ eFD
Julia Letlow House SELL ◆ insider convergence Self · Merrill Lynch Investment Account #025 2026-02-20 9 days -5.4% $1K–$15K
1.0% of NW
33.1 ↗ filing
Gilbert Cisneros House SELL ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2025-12-19 21 days -0.1% $1K–$15K
0.1% of NW
7.9 ↗ filing
Gilbert Cisneros House BUY ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2025-11-18 24 days +3.3% $1K–$15K
0.1% of NW
13.7 ↗ filing
Julia Letlow House BUY ◆ insider divergence Self · Merrill Lynch Investment Account #025 2024-10-23 292 days -25.5% $1K–$15K
1.0% of NW
66.0 ↗ filing
Daniel Goldman House SELL ◆ insider divergence · moderate Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K 2023-07-12 27 days — $50K–$100K
<0.1% of NW
61.4 ↗ filing
Daniel Goldman House BUY ◆ insider convergence · moderate Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K 2023-03-06 28 days — $15K–$50K
<0.1% of NW
90.9 ↗ filing
Kathy Manning House SELL Joint · Charles Schwab - O'Shaughnessy Asset Management 2022-08-03 34 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Christopher Jacobs House SELL Self 2020-09-08 44 days — $1K–$15K 75.9 ↗ filing
Gilbert Cisneros House SELL Self 2020-04-29 9 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Gilbert Cisneros House BUY Self 2020-03-18 28 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Mikie Sherrill House SELL Self 2020-02-20 12 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Thomas MacArthur House SELL Joint 2015-05-27 5 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in BXP — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
4
…with insider divergence
24
Insider open-market trades

Of the congressional trades in BXP, 3 coincided with corporate insiders moving the same way within 60 days, and 4 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-06-09 LABELLE MICHAEL E C-suite SELL $1.2M ↗ EDGAR
2026-06-09 LABELLE MICHAEL E C-suite SELL $538K ↗ EDGAR
2026-05-22 Kevorkian Eric G Other SELL $120K ↗ EDGAR
2026-05-21 Kevorkian Eric G Other SELL $12K ↗ EDGAR
2026-05-20 Otteni Peter V Other SELL $287K ↗ EDGAR
2026-02-27 Spann Hilary J. Other SELL $328K ↗ EDGAR
2026-02-13 THOMAS OWEN D C-suite SELL $73K ↗ EDGAR
2026-02-05 Spann Hilary J. Other SELL $76K ↗ EDGAR
2025-12-01 RITCHEY RAYMOND A Other SELL $2.6M ↗ EDGAR
2025-11-25 Otteni Peter V Other SELL $300K ↗ EDGAR
2025-11-12 Stroman John J Other SELL $1.2M ↗ EDGAR
2025-11-07 LABELLE MICHAEL E C-suite SELL $971K ↗ EDGAR
2025-03-05 Garesche Donna D C-suite SELL $145K ↗ EDGAR
2025-02-04 Spann Hilary J. Other SELL $892K ↗ EDGAR
2024-09-09 RITCHEY RAYMOND A Other SELL $1.6M ↗ EDGAR
2024-08-23 Otteni Peter V Other SELL $351K ↗ EDGAR
2024-03-06 RITCHEY RAYMOND A Other SELL $632K ↗ EDGAR
2024-03-06 RITCHEY RAYMOND A Other SELL $257K ↗ EDGAR
2023-09-11 Kevorkian Eric G Other SELL $66K ↗ EDGAR
2023-09-05 RITCHEY RAYMOND A Other SELL $3.4M ↗ EDGAR
2023-09-05 RITCHEY RAYMOND A Other SELL $1.0M ↗ EDGAR
2023-06-07 Otteni Peter V Other SELL $571K ↗ EDGAR
2023-05-26 Einiger Carol B. Director BUY $474K ↗ EDGAR
2023-03-15 LUSTIG MATTHEW J Director BUY $529K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-09-11 Rohit Khanna BUY $1K–$15K
◆ insider 2026-06-09 LABELLE MICHAEL E C-suite SELL $1.2M
◆ insider 2026-06-09 LABELLE MICHAEL E C-suite SELL $538K
◆ insider 2026-05-22 Kevorkian Eric G Other SELL $120K
◆ insider 2026-05-21 Kevorkian Eric G Other SELL $12K
◆ insider 2026-05-20 Otteni Peter V Other SELL $287K
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
◆ insider 2026-02-27 Spann Hilary J. Other SELL $328K
Congress 2026-02-20 Julia Letlow SELL $1K–$15K
◆ insider 2026-02-13 THOMAS OWEN D C-suite SELL $73K
◆ insider 2026-02-05 Spann Hilary J. Other SELL $76K
Congress 2025-12-19 Gilbert Cisneros SELL $1K–$15K
◆ insider 2025-12-01 RITCHEY RAYMOND A Other SELL $2.6M
◆ insider 2025-11-25 Otteni Peter V Other SELL $300K
Congress 2025-11-18 Gilbert Cisneros BUY $1K–$15K
◆ insider 2025-11-12 Stroman John J Other SELL $1.2M
◆ insider 2025-11-07 LABELLE MICHAEL E C-suite SELL $971K
◆ insider 2025-03-05 Garesche Donna D C-suite SELL $145K
◆ insider 2025-02-04 Spann Hilary J. Other SELL $892K
Congress 2024-10-23 Julia Letlow BUY $1K–$15K
◆ insider 2024-09-09 RITCHEY RAYMOND A Other SELL $1.6M
◆ insider 2024-08-23 Otteni Peter V Other SELL $351K
◆ insider 2024-03-06 RITCHEY RAYMOND A Other SELL $632K
◆ insider 2024-03-06 RITCHEY RAYMOND A Other SELL $257K

FAQ Common questions

How much has Congress traded BXP?

6 disclosed buys and 8 sells of BXP (Bxp, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade BXP?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.